NYSE - Delayed Quote USD

Avanos Medical, Inc. (AVNS)

12.65
+0.07
+(0.56%)
At close: May 9 at 4:00:02 PM EDT
13.15
+0.50
+(3.95%)
Pre-Market: 7:53:42 AM EDT
Loading Chart for AVNS
  • Previous Close 12.58
  • Open 12.64
  • Bid 5.06 x 900
  • Ask --
  • Day's Range 12.57 - 12.79
  • 52 Week Range 11.84 - 25.36
  • Volume 406,766
  • Avg. Volume 520,408
  • Market Cap (intraday) 584.987M
  • Beta (5Y Monthly) 1.14
  • PE Ratio (TTM) --
  • EPS (TTM) -8.27
  • Earnings Date Jul 29, 2025 - Aug 4, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 14.00

Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; OrthogenRx knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

avanos.com

2,227

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AVNS

View More

Performance Overview: AVNS

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

AVNS
20.54%
S&P 500 (^GSPC)
3.77%

1-Year Return

AVNS
35.03%
S&P 500 (^GSPC)
8.55%

3-Year Return

AVNS
50.76%
S&P 500 (^GSPC)
41.81%

5-Year Return

AVNS
54.97%
S&P 500 (^GSPC)
93.18%

Compare To: AVNS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AVNS

View More

Valuation Measures

Annual
As of 5/9/2025
  • Market Cap

    584.99M

  • Enterprise Value

    628.89M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.84

  • Price/Book (mrq)

    0.70

  • Enterprise Value/Revenue

    0.91

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -55.80%

  • Return on Assets (ttm)

    2.26%

  • Return on Equity (ttm)

    -36.78%

  • Revenue (ttm)

    689.2M

  • Net Income Avi to Common (ttm)

    -380.2M

  • Diluted EPS (ttm)

    -8.27

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    97M

  • Total Debt/Equity (mrq)

    16.79%

  • Levered Free Cash Flow (ttm)

    131.31M

Research Analysis: AVNS

View More

Company Insights: AVNS

Research Reports: AVNS

View More

People Also Watch